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PhosphatidylcholineApolipoprotein mediated formation of nanodisks was studied in detail using apolipophorin III (apoLp-III),
thereby providing insight in apolipoprotein–lipid binding interactions. The spontaneous solubilization of 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) vesicles occured only in a very narrow temperature range
at the gel–liquid–crystalline phase transition temperature, exhibiting a net exothermic interaction based on
isothermal titration calorimetry analysis. The resulting nanodisks were protected from proteolysis by trypsin,
endoproteinase Glu-C, chymotrypsin and elastase. DMPC solubilization and the simultaneous formation of
nanodisks were promoted by increasing the vesicle diameter, protein to lipid ratio and concentration.
Inclusion of cholesterol in DMPC dramatically enhanced the rate of nanodisk formation, presumably by
stabilization of lattice defects which form the main insertion sites for apolipoprotein α-helices. The presence
of fully saturated acyl chains with a length of 13 or 14 carbons in phosphatidylcholine allowed the
spontaneous vesicle solubilization upon apolipoprotein addition. Nanodisks with C13:0-phosphatidylcholine
were signiﬁcantly smaller with a diameter of 11.7±3.1 nm compared to 18.5±5.6 nm for DMPC nanodisks
determined by transmission electron microscopy. Nanodisk formation was not observed when the
phosphatidylcholine vesicles contained acyl chains of 15 or 16 carbons. However, using very high
concentrations of lipid and protein (N10 mg/ml), 1,2,-dipalmitoyl-sn-glycero-3-phosphocholine nanodisks
could be produced spontaneously although the efﬁciency remained low.II, apolipophorin III; DG, 1,2-
cero-3-phosphocholine; DPPC,
igh density lipoprotein; ITC,
r vesicle; MLV, multilamellar
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Apolipoproteins bear the intrinsic ability to solubilize phospho-
lipid vesicles forming small discoidal complexes, more recently
termed nanodisks [1]. The complexes can be seen as the most basic
lipoprotein particle containing one circular bilayer of phospholipid
surrounded by the apolipoprotein, which resembles the macromo-
lecular structure of nascent high density lipoprotein (HDL) found in
vivo [2]. Nanodisks are excellent particles for studies towards
understanding the structure of apolipoproteins in a lipid-bound
state as they are composed of one type of apolipoprotein and one
phospholipid species [3–5]. They can be used as platforms for
insertion of other membrane proteins or peptides, which can then
be analyzed in a well-deﬁned lipid environment [6]. The ability ofapolipoproteins to solubilize lipid vesicles has often been employed to
gain insight into the lipid binding properties of wild-type and mutant
apolipoproteins. It has been well established that vesicles of 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) can be solubilized
spontaneously at the phosphatidylcholine (PC) transition of the
ordered gel to the liquid crystalline phase by exchangeable apolipo-
proteins such as apolipoprotein (apo)A-I, apoE and insect apolipo-
phorin III (apoLp-III) [7–9]. ApoLp-III has been used as a model
apolipoprotein for structural and functional analysis [10]. This well-
studied apolipoprotein is relatively small (18 kDa), composed of a
bundle of amphipathic α-helices, and is monomeric in solution [11].
X-ray crystal and NMR solution structures are available for the
apolipoprotein from two different species [12–14]. The structure of
apoLp-III is similar to that of human apoA-I and apoE, showing all
bundles of amphipathic α-helices [15]. ApoLp-III is a more simple
protein with a single domain, while apoA-I and apoE are each
composed of two domains, probably a reﬂection of a more complex
function in vertebrate lipid transport processes [15–18]. Because of its
simplicity, apoLp-III is an excellent protein to study the lipid binding
properties of apolipoproteins. While it has often been used for
preparing nanodisks, a systematic study of the formation of these
increasingly popular particles is still lacking. This in contrast to human
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Jonas, Pownall, and others [1,7,19]. The present study aims to
investigate the factors that affect the transformation of DMPC vesicles
into nanodisks. This process, also known as vesicle solubilization, was
characterized in detail for apoLp-III from Locusta migratoria, and
included the susceptibility to proteases, the effect of phospholipid acyl
chain length, and inclusion of cholesterol, sphingomyelin and
diacylglycerol in DMPC vesicles. The results show that apoLp-III-
induced vesicle solubilization is similar to that observed for apoA-I,
indicating that a bundle of amphipathic helices is an attractive protein
scaffold to engage in lipid binding activity through insertion of
amphipathic α-helices in the PC vesicle bilayer.
2. Materials and methods
2.1. Recombinant protein
ApoLp-III was obtained from a well established recombinant
expression system [20]. Proteins expressed in E. coli escaped the
bacteria and accumulated in the culture medium from which they
were puriﬁed by G75 gel ﬁltration chromatography and reversed-
phase HPLC (Beckman System Gold) using a semi-preparative Zorbax
300SB column (Agilent Technologies, Santa Clara, CA) which typically
yielded 50 mg protein per liter culture medium. The purity of each
apoLp-III preparation was veriﬁed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) using precast 4–20%
gels (Invitrogen, Carlsbad, CA). Proteins were freeze-dried and stored
at −80 °C until further use. While the native protein is glycosylated,
the recombinant protein does not contain any N-linked carbohydrate
[21]. This has no signiﬁcant effect on the apoLp-III structure as the
NMR solution structure of recombinant apoLp-III and the X-ray
structure of native (glycosylated) apoLp-III produced very similar
high resolution structures [12,14].
2.2. Isothermal titration calorimetry
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) was dis-
solved in 2:1 chloroform methanol (v/v) with gentle vortexing. The
sample was dried under a stream of argon gas (Praxair, Canada) and
placed in vacuum (100 mmHg) for 12 h. The lipid ﬁlmwas rehydrated
at 40 °C in Tris buffer (20 mM Tris–HCl, 150 mM NaCl, 0.5 mM EDTA,
pH 7.2) with vortexing and bath sonication. The lipid vesicles
underwent extrusion through a 0.1 μM polycarbonate membrane 21
times (Avanti Polar Lipids, Alabaster, AL). The resulting large
unilamellar vesicles (LUV) were analyzed using dynamic light
scattering (Wyatt Technology Corporation, Santa Barbara, CA) to
test for radius and the concentration was determined using the Ames
phosphate test [22]. ApoLp-III was dissolved in Tris buffer with the
concentration determined using the extinction coefﬁcient at 280 nm.
Isothermal titration calorimetry (ITC) measurements were performed
with a MicroCal ITC200 titration calorimeter (GE Healthcare, North-
hampton, MA). The syringe was loaded with 24.45 mMDMPC (40 μL),
and the sample cell was ﬁlled with a 75 μM apoLp-III solution
(200 μL). Tris buffer was used in the reference cell (200 μL). The
experiment was performed at 24 °C with 20 injections spaced 150 s
apart in high feedback mode. A pre titration delay of 10 min with a
reference power of 5 μcal baseline and a ﬁlter period of 4 s was used.
The ﬁrst injection was 0.2 μL for a duration of 0.4 s. The remaining 19
injections were 2 μL for 4 s. The data was analyzed using MicroCal
Origin 7 ﬁtting to a 1 binding site model.
2.3. Vesicle solubilization
The following lipids were used in our analysis: 1,2-ditridecanoyl-SN-
glycero-3-phosphocholine (C13:0-PC), DMPC, 1,2-dipentadecanoyl-sn-
glycero-3-phosphocholine (C15:0-PC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), cholesterol, egg yolk sphingomyelin and 1,2-
dimyristoyl-sn-glycerol (DG) and were purchased from Avanti Polar
Lipids, Alabaster, AL. Dried pure lipids or theirmixtureswere rehydrated
in phosphate buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 2 mMKH2PO4, pH7.4) at 10 °C above the lipidphase transition
temperature, and vigorously vortexed to obtain multilamellar vesicles
(MLV). To obtain LUVs,MLVswere extruded 15 times usingvarious sizes
of membranes (Whatman nucleopore track-etch) in the mini-extruder
(Avanti Polar Lipids, Alabaster, AL). Tomeasure the vesicle solubilization
rate, MLVs or LUVs were incubated at their respective phase transition
temperatures. ApoLp-III, equilibrated at the same temperature, was
added to the vesicle suspension (1 mL total volume), and the change in
light scatter was measured in a spectrophotometer (Shimadzu UV-
2401PC equipped with a Peltier controlled cell holder) at 325 nm. To
measure the interaction of apoLp-III with DPPC bilayer vesicles, 6-
carboxyﬂuorescein (200 mM, Fluka Biochimica) was trapped into DPPC
vesicles by extrusion through 200 nm membranes. Vesicles were
separated from free carboxyﬂuorescein using a Sephadex G-75 column
(75×2.5 cm) and elution with PBS. Release of the DPPC encapsulated
dye was measured in a Fluoromax-2 ﬂuorometer using a 1:1 protein to
lipid mass ratio with an excitation wavelength of 480 nm and an
emission wavelength of 520 nm (3 nm slit width).
2.4. Characterization of nanodisks
The resultingnanodisks fromLUV-apoLp-III incubationswere isolated
by FPLC (AKTA puriﬁer, GE healthcare,Waukesha,WI), using a Superdex
200 10/300 GL size exclusion column. PBS was used as the elution buffer
with a ﬂow rate of 0.7 mL/min. The nanodisk fraction was collected, and
concentrated using 10 K spin column concentrators (Microcep, Pall Corp,
Ann Arbor, IL). The size of the nanodisks was estimated by native PAGE
using 4–20% Tris–glycine precast gels (Invitrogen, Carlsbad, CA). Gels
were run for 10 h at 125 V, and stainedwith naphthol blue black (Sigma-
Aldrich, St. Louis, MO). Transmission electron microscopy (TEM) was
used to visualize the nanodisk preparations. Tenmicroliters of a nanodisk
solution (containing 28 μg phospholipid and 10 μg apoLp-III) was
absorbed to a hydrophilized 300-mesh carbon coated copper formvar
ﬁlm (EM Science) and rinsed once with PBS. Samples were negatively
stained for 15 s with 5 μl 2% sodium phosphotungstate, pH 7.4. Electron
micrographs were obtained with a Joel JEM 1200 EX-II electron
microscope operated at 100 kV. About 75 nanodisks were measured
from a preselected grid to determine their dimension.
2.5. Proteolysis analysis
Nanodisks were isolated by size exclusion chromatography (Super-
dex-200, GE), and incubated with trypsin (gold mass spec grade,
Promega), Endoproteinase Glu-C (sequencing grade, Roche Applied
Science), chymotrypsin (sequencing grade, Promega), or elastase
(human leukocytes, Sigma-Aldrich). Trypsin incubations were carried
out in 50 mM NH4HCO3, pH 8.2; endoproteinase Glu-C in 25 mM
NH4HCO3, pH 7.8; chymotrypsin in 100 mM Tris–HCl, 10 mM CaCl2, pH
7.8; and elastase in 50 mMNaH2PO4, pH 6.5. The digests were separated
by 16% Tris–tricine SDS-PAGE (Bio-Rad Laboratories). Protein bands in
endoproteinase Glu-C digests were blotted to nitrocellulose and N-
terminal sequence analysis was carried out at the UC Davis Proteomics
Core Facility, providing two sequences: DAAGHV and AEKHQG. The size
of the fragments was determined by MALDI-TOF (Applied Biosystems
4800)using sinapinic acid as thematrix (IIRMES facility, CSULongBeach).
3. Results
3.1. Temperature dependence of DMPC vesicle solubilization
The apolipoprotein-induced spontaneous transformation of DMPC
vesicles into nanodisks is a temperature-dependent process [7].
Fig. 2. ITC binding analysis of apoLp-III to DMPC vesicles at 24 °C. Each time, 2 μL of
DMPC (24.45 μM) was injected into a solution of 200 μL apoLp-III (75 μM) with 150 s
time intervals. Top: titration proﬁle of the raw data in which each peak represents the
heat released by a single injection after baseline subtraction. Bottom: binding isotherm
generated from the integrated heat for each injection and plotted against the molar
ratio of lipid to protein.
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relatively fast when carried out at the narrow temperature range
between 23 and 24 °C. The transformation was measured spectro-
photometrically at 325 nm and the solubilization of the phospholipid
vesicles is evident by a decrease in vesicle light scatter intensity. No
signiﬁcant vesicle solubilization rate was observed at or below 22 or
above 25 °C (Fig. 1). Since the sample turbidity remained steady
outside this narrow temperature range, this raised the question
whether apoLp-III associated with the vesicle surface with no
transformation into nanodisks. Therefore, apoLp-III and DMPC LUVs
were incubated at 4 °C, followed by the separation of LUVs from lipid-
free protein by size exclusion chromatography. The lipid fraction was
analyzed by SDS-PAGE and did not contain measurable amounts of
protein (Fig. 1B), indicating a lack of a stable binding interaction of
apoLp-III with the LUVs at 4 °C. In addition, the parameters of the
apoLp-III interaction with DMPC SUVs were determined by ITC. The
total process was exothermic, with a ΔH of−7.6⋅103 kcal/mol and a
ΔS of−5.52 cal/mol/deg at 24 °C (Fig. 2). The equilibrium constant of
dissociation (KD) was estimated at 4.4 ⋅10−5 M, however this value
does not only result from the binding interaction but also includes the
conversion of vesicles into nanodisks. No measurable binding
parameters of apoLp-III to DMPC vesicles could be obtained at 4 or
at 37 °C, a result similar to the chromatography analysis.
3.2. Susceptibility to proteases
Previous guanidine–HCl denaturation analysis has shown that the
midpoint of locust apoLp-III denaturation increased from 0.6 to
approximately 3 M, indicating that DMPC nanodisks are exceptionally
stable particles [11]. This led us to explore the susceptibility of the
nanodisks to protease activity. Four different proteases with various
speciﬁcities to digest apoLp-III in the lipid-free form and in nanodisks
were employed: trypsin, endoproteinase Glu-C (V8 protease),
chymotrypsin, and elastase. In this manner the susceptibility to
hydrolysis at positively and negatively charged, hydrophobic, and
aromatic amino acid residues was analyzed. In the lipid-free form,
trypsin fully cleaved apoLp-III into small fragments (enzyme/protein
mass ratio of 1:1000); Tris–tricine gels showed the larger products of
4.9 and 4.2 kDa which is close to the expected sizes of 5341 and
4275 Da based on the amino acid sequence (Fig. 3). However, the
protein was completely protected from proteolysis when bound to
DMPC, even after a 10-fold increase in the enzyme to protein ratio.
Addition of endoproteinase Glu-C to lipid-free apoLp-III also led to a
complete digestion, with the largest visible fragment of 5.2 kDa
(expected size 5791 kDa). While DMPC-bound apoLp-III was signif-
icantly protected, two protein bands appeared in the 10–14 kDaFig. 1. Temperature dependence of DMPC solubilization. DMPC vesicles were incubated
with apoLp-III at the indicated temperatures, and from the decrease in sample
absorbance the initial rate constants were obtained. Inset: SDS-PAGE analysis of DMPC/
apoLp-III incubation at 37 °C; lane 1: marker; lane 2: lipid-free fraction, lane 3: lipid
fraction.region. MALDI-TOF and N-terminal amino acid sequence analysis
showed that partial hydrolysis at Glu-63 was responsible for the
appearance of the 10.6 kDa fragment, while the larger fragment was
likely a result of hydrolysis at Glu-126. Nevertheless, the other 11 Glu
residues were not susceptible for endoproteinase Glu-C hydrolysis
when the protein was bound to DMPC. Chymotrypsin and elastase
completely digested apoLp-III, and did not produce discrete bands
on the gel as the peptides were too small to be resolved by Tris–tricine
SDS-PAGE (results not shown). On the other hand, incubation of
DMPC-bound apoLp-III with these two enzymes did not result in
hydrolysis, as the intensity of the intact protein remained unchanged.
This result shows that the protein is considerably protected from
proteases when in complex with DMPC.
3.3. Vesicle parameters
Both MLVs and LUVs were used as the starting point for nanodisk
preparations. MLVs were made by vigorously mixing a dried lipid ﬁlm
with buffer, while for LUVs the MLVs were extruded through
membranes with narrow pores. LUVs were converted into nanodisks
at a faster rate compared to MLVs (not shown). Increasing the protein
to lipid ratio, from 1:2 to 3:1 (w/w) resulted in signiﬁcantly faster
solubilization rates (Fig. 4A). Next, the solubilization rate of LUVs with
different sizes was measured. LUVs prepared by extrusion through
50 nmmembranes were converted at a relatively slow rate, while the
rate progressively increased using vesicles prepared with 100 nm or
200 nm ﬁlters (Fig. 4B). Increased concentrations of protein and lipid,
maintaining their 2:1 protein to lipid mass ratio, also resulted in
substantial faster rates (Fig. 4C). Based on these experiments, 500 μg
Fig. 3. Proteolysis of lipid-free and lipid-bound apoLp-III (DMPC nanodisks). Top panel:
trypsin incubations of apoLp-III. Lane 1: apoLp-III+trypsin (1:1000 mass ratio); lane 2
apoLp-III. Lanes 3–8 contain lipid-bound apoLp-III incubated with trypsin with apoLp-
III/trypsin mass ratios of 1:100 (lane 3), 1:200 (lane 4), 1:400 (lane 5), 1:500 (lane 6),
1:1000 (lane 7), or no trypsin (lane 8). Bottom panel shows apoLp-III incubated with
endoGlu-C. Lanes 1 and 2: apoLp-III in the presence (lane 1) or absence (lane 2) of
endoGlu-C (1:100); lanes 3–5: lipid-bound apoLp-III with endoGlu-C 1:75 (lane 3),
1:100 (lane 4), and no protease (lane 5).
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with 1000 μg of apoLp-III in a 1 mL total volume was used for
subsequent LUV solubilization analysis. The use of these parameters
ensures reasonably fast and reproducible solubilization rates.
3.4. Effect of phosphatidylcholine acyl chain length
The possibility to employ DPPC LUVs to measure their rate of
solubilization was explored as acyl chains with 16 carbons are
abundantly found in lipoprotein phospholipids. However, apoLp-III
was unable to induce a decrease in sample turbidity of a suspension of
DPPC LUVs at the phase transition temperature (Fig. 5A). In addition,
ﬂuorescein encapsulated in DPPC vesicles could not be released by the
addition of apoLp-III, indicating a lack of solubilization (Fig. 5B). TheFig. 4. DMPC solubilization. ApoLp-III was mixed with DMPC vesicles and the decrease in sam
with 250, 500, 1000 or 1500 μg apoLp-III. (B) apoLp-III incubated with 500 μg of DMPC vesic
apoLp-III at a 1:2 lipid to protein ratio (mass).inability of apoLp-III to solubilize DPPC vesicles at the phase transition
of DPPC (41 °C) is likely not due to protein unfolding as the midpoint
of temperature denaturation for apoLp-III is 53 °C [23]. Decreasing the
acyl chain length by one carbon (using dipentadecanoyl phosphati-
dylcholine, phase transition temperature 31 °C) did not result in
vesicle solubilization. On the other hand, PC vesicles bearing two
saturated acyl chains of 13 carbons (ditridecanoylphosphatidylcho-
line) were solubilized at a strongly enhanced rate compared to DMPC.
The decrease in sample turbidity of C13:0-PC LUVs was accompanied
by the formation of discoidal complexes, as shown by native PAGE
analysis (Fig. 6A). The C13:0-PC nanodisks were substantially smaller
compared to that of DMPC, with an apparent molecular mass of
250 kDa compared to 450 kDa for DMPC complexes. Transmission
electron microscopic analysis showed a diameter of 11.7±3.1 nm for
C13:0-PC and 18.5±5.6 nm for DMPC nanodisks (Fig. 6B).
3.5. Effect of cholesterol, DG and SM
Cholesterol is abundantly present in HDL [24]. Since nascent HDL
has a structure similar to that of apoLp-III nanodisks, the effect of
cholesterol in LUVs on the vesicle solubilization rate was investigated.
Inclusion of 5% or 10% of cholesterol (mole%) in DMPC LUVs had a
dramatic effect and increased the solubilization rate by 4- and 6-fold,
respectively (Fig. 7). In contrast, cholesterol contents of 20% and
higher prevented the solubilization of LUVs. TEM analysis showed that
inclusion of cholesterol in DMPC produced slightly larger nanodisks
(diameter of 18.5±5.6 nm versus 22.6±3.1 nm). The positive effect
of cholesterol for DMPC LUV solubilization led us to explore the
possibility to convert cholesterol enriched DPPC LUVs. However,
inclusion of cholesterol in DPPC LUVs did not result in a measurable
decrease in sample turbidity, indicating that no signiﬁcant amounts of
nanodisks were formed. Since an increase in DG content in insect
lipoproteins is the trigger for apoLp-III binding in vivo, it was tested if
DGwas able to enhance DMPC solubility rates similar to cholesterol. In
addition, SM was used as this is a major HDL lipid component and
increased binding was observed in DMPC/SM LUV mixtures (40:60%
mol) using differential scanning calorimetric analysis [25]. Surpris-
ingly, addition of neither DG nor SM did result in increased solubility
rates. Instead, the ability to form nanodisks was signiﬁcantly
hampered in these lipid mixtures (not shown).
While isolating the lipid fraction of DPPC LUV/apoLp-III incuba-
tions to verify the presence of apoLp-III on the vesicle surface, SDS-
PAGE analysis indicated the presence of small amounts of apoLp-III.
Subsequent TEM analysis surprisingly showed the presence of
nanodisks. This prompted us to investigate the ability to solubilize
DPPC vesicles in more detail. To detect apoLp-III in the LUV fraction,
the concentration of protein and lipid was increased to 10 mg/mL and
incubated for several hours. This 10-fold increase in protein and lipid
concentration may have driven the formation of nanodisks, andple absorbance monitored for the times indicated. (A) 500 μg of DMPC was incubated
les with a diameter of 50, 100 or 200 nm. (C) 125, 250, or 500 μg DMPC incubated with
Fig. 5. (A) The effect of acyl chain length of phospholipid vesicles on the solubilization
rate. Incubations were carried out at the lipid phase transition temperature. Shown are
C13:0-PC, DMPC (C14), C15:0-PC, and DPPC (C16). (B) release of carboxyﬂuorescein
from DPPC vesicles after addition of apoLp-III or Triton X-100.
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tion. Inclusion of SM (60%) into DPPC vesicles, either LUV or MLV,
signiﬁcantly improved the yield of nanodisks. Of the total amount of
protein used, 1.76±0.01% protein was recovered in the lipid fraction
of DPPC LUV incubations. The recoverywas improved to 10.50±1.09%
(n=3) when using the SM/DPPC vesicles. The resulting SM/DPPC
disks were substantially smaller compared to pure DPPC nanodisks as
indicated by native PAGE analysis (~450 kDa for the mixture and
~700 kDa for pure DPPC nanodisks, results not shown). Based on the
sample turbidity measurements, more than 80% of the vesicles were
not converted into nanodisks. Nevertheless, these results demon-
strate that apoLp-III is able to solubilize DPPC vesicles spontaneously
albeit at a very low yield, and that inclusion of SM improved their
formation.
4. Discussion
The ability to form nanodisks has been used extensively in studies
investigating the lipid binding properties of apolipoproteins, in
particular apoA-I, apoE and apoLp-III [26]. DMPC is often used to
produce nanodisks as this synthetic PC is commercially available and
inexpensive, a detergent (such as sodium cholate) is not required, andthe rate of LUV solubilization, and thus formation of nanodisks can be
readily determined spectrophotometrically at the DMPC phase
transition temperature of 24 °C. Conversely, a ﬂuorometer can be
used when the excitation and emission wavelength are set at identical
values to measure right angle light scatter. To follow the conversion of
DMPC vesicles into nanodisks, the cuvette temperature needs to be
maintained at a constant temperature of 24±0.2 °C as small changes
in temperature can lead to a substantial change in solubilization rate,
and therefore a peltier controlled cuvette holder or a refrigerated
circulating water bath is highly recommended.
The most dramatic effects in apolipoprotein–lipid binding inter-
action using DMPC liposomes have been observed in apolipoproteins
in which the helices have been tethered by disulﬁde bonds after
introduction of closely spaced cysteine residues. The oxidized protein
is then maintained in a permanently closed state, unable to undergo
the transition to an open conformation. Many of these mutants lost
their ability to solubilize DMPC vesicles; however, following cystine
reduction, the ability to solubilize the vesicles was restored [27–30].
More subtle changes in lipid binding can also be measured, for which
an accurate determination of the rate of solubilization is necessary.
Measuring DMPC solubilization rates has been used successfully to
demonstrate a molten globule-like state of the apolipoprotein at low
pH which facilitates lipid binding [31–33], establish an inverse
correlation between lipid binding and apolipoprotein stability for
apoE and apoLp-III [17,23,34], and used for the lipid binding analysis
of truncation mutants of apoA-I and apoA-V [35–37].
For accurate measurement of the solubilization rate, LUVs
prepared by extrusion are preferred over MLVs as it is straightforward
to produce vesicles with a homogeneous diameter by extrusion,
limiting batch to batch variation and the need for vesicle fractionation
by size exclusion chromatography to obtain the desired diameter. As
shown in the present study, vesicle diameter was inversely correlated
with the solubilization rate. However, one would expect that
the increased curvature enhances the strain of the phospholipid
bilayers, rendering the bilayers more susceptible for apolipoprotein
insertion as reported earlier for the interaction of apoA-I with DPPC
vesicles [38]. According to the present data, a protein to lipid ratio of
2:1 (w/w), using 1 mg protein and 0.5 mg of 200 nm LUVs in a total
volume of 1 mL, provided relatively quick and reproducible results.
Using these conditions approximately 90% of the vesicle population
was converted into nanodisks within 30 min. Human apolipoproteins
may require other protein to lipid ratios as the intrinsic ability to
interact with the phospholipid bilayers may be different. Too much
protein may result in extensive solubilization during mixing of LUVs
with the protein sample, and initial rate constants will be difﬁcult to
obtain. In a scenario where the apolipoprotein is unable to solubilize
vesicles at a sufﬁcient rate, cholesterol can be incorporated into the
bilayer vesicles. While apoLp-III is monomeric in solution, other
apolipoproteins are often present in a multimeric state and this
decreases the solubilization rate [39]. Addition of low amounts of
guanidine–HCl has been used to minimize such protein-protein
interactions [9].
Comparison of binding parameters between L. migratoria apoLp-III
and other previously studied apolipoproteins is complex, as calorim-
etry has not been used before to separate the energy from lipid
binding and nanodisk formation. ApoA-I binding to pure 1-palmitoyl-
2-oleoylphosphatidylcholine mixtures with cholesterol was calculat-
ed assuming minimal lipid vesicle perturbation in conditions that did
not produce nanodisks [40]. Our data correlates with ΔH values
derived for many different plasma apolipoproteins to DMPC whereby
the majority reveal a dominant negative enthalpy including apoA-I,
apoA-II, apoC-III and apoE [40,41]. Hence it is likely that the binding of
apoLp-III to vesicles is exothermic; however, more thermodynamic
information about nanodisk formation is required to conﬁrm this. The
large negative enthalpy suggests an increase in bonding which
includes protein-vesicle and intermolecular protein interactions, as
Fig. 6. (A) Native PAGE analysis of nanodisks. Lane 1: marker proteins; lane 2: DMPC nanodisks; lane 3: DMPC/cholesterol 90:10 nanodisks; lane 4: C13:0-PC nanodisks.
(B) Transmission electron microscopy of DMPC nanodisks (a), DMPC/cholesterol 90:10 nanodisks (b), C13:0-PC nanodisks (c), and DMPC vesicles (d).
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the DMPC vesicles increasing the van der Waals interactions between
hydrophobic faces of the α-helices and the hydrophobic areas of the
bilayers yielding a negativeΔH. Such interactionsmay reduce the lipid
mobility and the corresponding reduction in entropy would correlate
with our calorimetric ﬁnding and the nanodisk model [40].
Boundaries between phospholipid molecules in the gel and liquid
state, which occur in the vicinity of the phase transition temperature,
likely promote the ability of apoLp-III to solubilize the vesicles, similaras observed for apoA-I [42]. At the phase transition temperature
maximum ion permeability [43] and ﬂip-ﬂop [44] have been
observed. It appears that pores that develop at such lattice defects
form a suitable surface for insertion of the α-helical segments of
apolipoproteins, subsequently reorganizing the bilayers vesicles into
discoidal particles in a 2nd step. During this binding event, apoLp-III
undergoes a dramatic reorganization of itsα-helices, switching from a
closed helix bundle to an open conformation in which the protein is
fully stretched and circumvents the periphery of the discoidal particle
Fig. 7. Effect of cholesterol on the DMPC vesicles solubilization rate. Shown are pure
DMPC (a, solid line), and DMPC vesicles enrichedwith 5% (b, dashed line) 10% (c, dotted
line), 20% (d, dash-dotted line) and 30% (e, double dot-dashed line) cholesterol.
612 C.-P.L. Wan et al. / Biochimica et Biophysica Acta 1808 (2011) 606–613[45,46]. This organization is strikingly similar to models proposed for
apoA-I and apoE [4,5].With a diameter of 17 nm, it was calculated that
the particle contains four molecules of apoLp-III and ~800 molecules
of phospholipid [45]. In addition, nanodisks with other dimensions
have been generated by varying the DMPC to apoLp-III ratio, resulting
in a different stoichiomtry [47]. A population of nanodisks was
generated with a 10.7 nm diameter which contained two apoLp-III
molecules. The C13-PC nanodisks produced in our study were similar
in diameter which would accommodate approximately two apoLp-III
molecules on the disk periphery.
No stable binding interaction of apoLp-III with DMPC was
observed below or above the DMPC phase transition temperature.
Thus, phospholipids in either an ordered gel or liquid-crystalline
phase are not suitable platforms for apoLp-III binding, emphasizing
the need for coexisting phases and the resulting boundaries. At the
phase transition temperature, ﬂuctuations of phospholipid clusters
between the gel and liquid states result in localized volume changes,
causing lattice defects [48]. Additional methylene groups had a strong
stabilizing effect on the vesicles: an increase in phospholipid acyl
chain length from 14 to 15 or 16 carbons nearly abolished the ability
of apoLp-III to spontaneously transform the vesicles into nanodisks.
Only at very high lipid and protein concentrations (in the order of 10–
20 mg mL−1) low amounts of nanodisks were formedwith DPPC. This
result is similar to apoA-I in which the spontaneous solubilization of
DPPC appears to be much slower compared to DMPC with an
equilibrium time in the order of days [49]. The tight packing of
phosphatidylcholine with acyl chains lengths of 15 or larger in bilayer
vesicles results in increased van der Waals interactions, which form a
barrier more difﬁcult to overcome and thus minimizes the apolipo-
protein-mediated solubilization. On the other hand, C13:0-PC was
solubilized about 20-fold faster compared to DMPC. In addition,
dilauroylphosphatidylcholine vesicles have been shown to be less
stable and are poor permeability barriers to ions, and as the acyl chain
length exceeds 14 carbons, the membrane becomes more stable and
less permeable [43]. Other studies have shown that the coexistence of
gel and ﬂuid domains in membranes promote passive permeation of
trapped small molecules, and the rate of ﬂip-ﬂop increases with
shorter acyl chain length [50,51]. Thus, it is conceivable that the
degree of lattice defects increases as the acyl chain length decreases,
explaining the order of magnitude faster solubilization rates of C13:0-
PC vesicles.
Inclusion of SM into DPPC vesicles resulted in higher yields of the
nanodisks. This supports our previous ﬁnding that the interaction of
apoLp-III was strongest in DMPC/SM (40:60 mol/mol) mixtures, and a
less optimal DMPC packing led to surface defects promoting
solubilization [24]. This is also in agreement with the enhanced
formation of apoA-I containing nanodisks using DPPC/SM mixtures
with increasing amounts of SM [52]. Surprisingly, DG inclusion did notpromote vesicle solubilization, while in vivo the increased DG content
in lipophorins elicits the association of apoLp-III with the lipoprotein
surface [53]. It is possible that DG inclusion in the PC bilayers may not
result in packing defects but form isolated domains within the PC
vesicles. In addition, increased DG content signiﬁcantly reduces the
ability to form stable LUVs, and the DG amount required to form
packing defects may not be reached. Inclusion of 10% cholesterol into
DMPC bilayers substantially increased the solubility by apoLp-III. This
is similar as observed for apoA-I, for which an optimum of 12.5%
cholesterol resulted in the fastest solubilization rate [54]. Cholesterol
contents of 20% and higher prevented the nanodisk formation. It has
been shown that increased cholesterol incorporation into 14:0-PC
bilayers resulted in a strong decrease of the main phase transition as
shown in DSC endotherms, which completely disappeared at 50%
cholesterol [55]. The absence of a phase transition likely explains the
lack of interaction of apoLp-III with PC vesicles with high cholesterol
contents. The slightly larger size of cholesterol containing apoLp-III
nanodisks is consistent with data published for apoA-I in which
cholesterol rich vesicles led to an increase in size of the resulting
reconstituted HDL particles [56,57]. Themaximum solubilization rates
with apoA-I are found at the phase transition of DMPC, and the rate
can bemodulated by increasing the amount of surface defects induced
by cholesterol [7,56,57]. The authors conclude that cholesterol
drastically broadens the gel and liquid phases and signiﬁcantly alters
the lipid packing, promoting the binding of apoA-I. The insertion of α-
helical segments into these lattice defects are considered as the rate-
limiting step. Subsequently, protein/lipid complexes bud off from the
vesicle surface and form the characteristic nanodisks as outlined in
detail in a model proposed by Segall et al. [9].
ApoLp-III shares many similarities with human apoA-I. Both are
bundles of amphipathic α-helices with an up-and-down topology,
and the proteins rapidly form nanodisks when incubated with
phospholipids at the phase transition temperature. When lipid
packing defects were introduced this led to signiﬁcant increases in
vesicle solubilization rates and formation of nanodisks. It appears that
the helix bundle motif found in several apolipoproteins seems to be
well suited for insertion of one or more helical segments into the lipid
surface, enabling the transition from a lipid-free to amore stable lipid-
bound form of the protein. The nanodisksmade of DMPC and apoLp-III
are exceptionally stable and can be stored at 4 °C for months [47]. The
lipid-bound apolipoprotein is not only more stable in terms of protein
folding, but is also signiﬁcantly more resistant against protease
activity as shown in the present study and by others [58]. This can be
exploited when using the nanodisks as a drug delivery vehicle.
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